Showing results (251-260 of 306) with videos related to

Sort By:
Pageof 31
Arthritis and Rheumatism|December 31, 1998
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonistB Bresnihan, J M Alvaro-Gracia, M Cobby, et al.
Annals of the Rheumatic Diseases|October 13, 2010
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trialP P Tak, W F Rigby, A Rubbert-Roth, et al.
Arthritis and Rheumatism|December 1, 1994
Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissueP P Tak, J A Kummer, C E Hack, et al.
Ebiomedicine|May 24, 2016
Autonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort StudyF A Koopman, M W Tang, J Vermeij, et al.
Annals of the Rheumatic Diseases|April 15, 2004
T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritisM C Kraan, J J Haringman, H Weedon, et al.
Arthritis and Rheumatism|August 16, 2000
Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centersM C Kraan, R J Reece, E C Barg, et al.
Arthritis and Rheumatism|August 18, 2001
Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammationP P Tak, D M Gerlag, K R Aupperle, et al.
Arthritis and Rheumatism|June 3, 2008
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapyE Keystone, G R Burmester, R Furie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1992
Unusual manifestations of Yersinia enterocolitica infections diagnosed using novel methodsP P Tak, L G Visser, J A Hoogkamp-Korstanje, et al.
Annals of the Rheumatic Diseases|March 24, 2012
Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritisR Klaasen, M M J Herenius, C A Wijbrandts, et al.
Pageof 31